MedTrace Logo

Efficacy & Safety of Clindamycin and Tretinoin in Acne

NCT01111994 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2010-05-20

No results posted yet for this study

Summary

The purpose of this study is ascertain the efficacy and safety of Clindamycin

Phosphate 1.2% and Tretinoin 0.025% in the treatment of Acne and Post

Inflammatory Hyperpigmentation in patients with skin of color.

Conditions

Interventions

DRUG

Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel

Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel QD for 3 months

Sponsors & Collaborators

  • Society Hill Dermatology

    collaborator OTHER

  • Callender Center for Clinical Research

    lead OTHER

Principal Investigators

  • Valerie Callender, MD · Callender Center for Clinical Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-03-31
Completion
2010-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01111994 on ClinicalTrials.gov